Cargando…

Hepatitis C virus to hepatocellular carcinoma

Hepatitis C virus causes acute and chronic hepatitis and can lead to permanent liver damage and hepatocellular carcinoma (HCC) in a significant number of patients via oxidative stress, insulin resistance (IR), fibrosis, liver cirrhosis and HCV induced steatosis. HCV induced steatosis and oxidative s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahan, Shah, Ashfaq, Usman A, Qasim, Muhammad, Khaliq, Saba, Saleem, Muhammad Javed, Afzal, Nadeem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293064/ https://www.ncbi.nlm.nih.gov/pubmed/22289144 http://dx.doi.org/10.1186/1750-9378-7-2

Ejemplares similares

Inhibition of Hepatitis C Virus 3a genotype entry through Glanthus Nivalis Agglutinin
por: Ashfaq, Usman A, et al.
Publicado: (2011)

siRNAs: Potential therapeutic agents against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line
por: Jahan, Shah, et al.
Publicado: (2011)

Association of laboratory parameters with viral factors in patients with hepatitis C
por: Ijaz, Bushra, et al.
Publicado: (2011)

Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA
por: Ali Ashfaq, Usman, et al.
Publicado: (2011)

Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs
por: Khaliq, Saba, et al.
Publicado: (2011)

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy
por: Ahmed, Uzair, et al.
Publicado: (2021)

Role of viral and host factors in interferon based therapy of hepatitis C virus infection
por: Imran, Muhammad, et al.
Publicado: (2013)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
por: Khaliq, Saba, et al.
Publicado: (2018)

Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015)

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA
por: Ansar, Muhammad, et al.
Publicado: (2011)

Estimation of Hepatitis B Virus, Hepatitis C Virus, and Different Clinical Parameters in the Thalassemic Population of Capital Twin Cities of Pakistan
por: Saeed, Umar, et al.
Publicado: (2015)

In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus
por: Javed, Tariq, et al.
Publicado: (2011)

Transition of Antibody to Hepatitis C Virus from Chronic Hepatitis to Hepatocellular Carcinoma
por: Kiyosawa, Kendo, et al.
Publicado: (1990)

In-vitro model systems to study Hepatitis C Virus
por: Ashfaq, Usman Ali, et al.
Publicado: (2011)

Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
por: Rehman, Sidra, et al.
Publicado: (2011)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma
por: Hibner, Urszula, et al.
Publicado: (2015)

Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review
por: Axley, Page, et al.
Publicado: (2017)

HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development
por: Idrees, Sobia, et al.
Publicado: (2013)

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
por: Plissonnier, Marie-Laure, et al.
Publicado: (2018)

Hepatitis D Virus and Hepatocellular Carcinoma
por: Farci, Patrizia, et al.
Publicado: (2021)

Hepatitis B and C in Pakistan: A community survey
por: Javed, Nismat, et al.
Publicado: (2019)

Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis
por: Sufyan, Muhammad, et al.
Publicado: (2021)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes
por: Ali, Muhammad, et al.
Publicado: (2011)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
por: Oe, Natsumi, et al.
Publicado: (2022)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Rizzo, Giacomo Emanuele Maria, et al.
Publicado: (2022)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
por: Shen, Chen, et al.
Publicado: (2023)

Dataset of knowledge, attitude, practices and psychological implications of healthcare workers in Pakistan during COVID-19 pandemic
por: Qasim, Muhammad, et al.
Publicado: (2020)

Coinfection of Hepatitis B and Hepatitis C Virus in Patients With Human Immunodeficiency Virus
por: Masroor, Hassan, et al.
Publicado: (2021)

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region
por: Kim, Mi Na, et al.
Publicado: (2013)

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
por: Bruno, Savino, et al.
Publicado: (2011)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_34uf3lgtdabb050vsocrc78jla